ArticleCureus2025
Evaluation of the Safety and Efficacy of Ganga Water-Phage Therapy Plus Standard Medical Therapy Compared to Standard Medical Therapy Alone for Helicobacter pylori-Related Dyspepsia: A Randomized Controlled Trial.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy and Safety Outcomes of Bacteriophage Therapy for Resistant Bacterial Infections.Cureus · 2026Review
- Phage Therapy in Gastrointestinal Diseases: Current Status and Challenges.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDyspepsia is a prevalent gastrointestinal condition in India, commonly linked to
objectiveThis study aimed to evaluate the safety and efficacy of GWPT combined with SMT versus SMT alone in
methodsThis prospective, randomized, controlled, open-label clinical trial was conducted between March 2025 and July 2025 at two tertiary-care centers in northern India: Rajarshi Dashrath Autonomous State Medical College, Ayodhya, and King George's Medical University (KGMU), Lucknow. In this randomized controlled trial (CTRI/2024/07/070007), 50 adults aged 18-65 years with confirmed
resultsEradication rates were 66.7 % for SMT and 69.2 % for SMT + GWPT (p = 1.000). Both groups improved significantly in symptom and quality-of-life measures, with numerically greater gains in the GWPT arm. Adverse events were mild (abdominal discomfort, nausea, gastritis, and belching); no serious toxicity occurred.
conclusionGWPT, when added to SMT, marginally enhances
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.